These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9115007)

  • 1. Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogesterone acetophenide and 6 mg estradiol enanthate.
    Coutinho EM; Spinola P; Barbosa I; Gatto M; Tomaz G; Morais K; Yazlle ME; de Souza RN; Pinho Neto JS; Leal Wde B; Leal C; Hippolito SB; Abranches AD
    Contraception; 1997 Mar; 55(3):175-81. PubMed ID: 9115007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, acceptability, and clinical effects of a low-dose injectable contraceptive combination of dihydroxyprogesterone acetophenide and estradiol enanthate.
    Coutinho EM; Spinola P; Tomaz G; Morais K; Nassar de Souza R; Sabino Pinho Neto J; de Barros Leal W; Bomfim Hippolito S; D'Aurea Abranches A
    Contraception; 2000 Apr; 61(4):277-80. PubMed ID: 10899484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive.
    Recio R; Garza-Flores J; Schiavon R; Reyes A; Diaz-Sanchez V; Valles V; Luz de la Cruz D; Oropeza G; Perez-Palacios G
    Contraception; 1986 Jun; 33(6):579-89. PubMed ID: 3769482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of "once-a-month" combined injectable contraceptives.
    Newton JR; D'arcangues C; Hall PE
    J Obstet Gynaecol (Lahore); 1994; 4 Suppl 1():S1-34. PubMed ID: 12290848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal bleeding patterns in users of Perlutal, a once-a-month injectable contraceptive consisting of 10 mg estradiol enanthate combined with 150 mg dihydroxyprogesterone acetophenide. A trial of 5462 woman-months.
    Martínez GH; Castañeda A; Correa JE
    Contraception; 1998 Jul; 58(1):21-7. PubMed ID: 9743892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J; Müller U; Düsterberg B
    Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive.
    Schiavon R; Benavides S; Oropeza G; Garza-Flores J; Recio R; Díaz-Sanchez V; Pérez-Palacios G
    Contraception; 1988 Jun; 37(6):591-8. PubMed ID: 3396358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate.
    Coutinho EM; Spinola P; Athayde C; Noronha CF; de Melo NR; Cabral ZA; Almeida JA; da Silva BL; Neto JS; Rumi DO
    Contraception; 2006 Mar; 73(3):249-52. PubMed ID: 16472564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation inhibition with a log-acting injectable. II. The cycling effects of varying progestagen-estrogen combinations.
    Rizkallah TH; Taymor ML
    Am J Obstet Gynecol; 1966 Jan; 94(2):161-4. PubMed ID: 5900652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
    Hall P; Bahamondes L; Diaz J; Petta C
    Contraception; 1997 Dec; 56(6):353-9. PubMed ID: 9494768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conception control by a single monthly injection.
    Esquivel A; Laufe LE
    Obstet Gynecol; 1968 May; 31(5):634-6. PubMed ID: 5646393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
    Garza-Flores J; Alba VM; Cravioto MC; Hernandez L; Perez-Palacios G; Alvarado G; Rivera R; Recio R; Bassol S
    Contraception; 1989 May; 39(5):519-29. PubMed ID: 2524362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.